Improving how parents help their children take cancer medications
Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence
This study is looking at how to help parents support their young children with Acute Lymphoblastic Leukemia in taking their medicine regularly, using a new program called CareMeds that gives parents helpful tips and strategies.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10994065 on NIH RePORTER |
What this research studies
This research focuses on enhancing medication adherence among young children with Acute Lymphoblastic Leukemia (ALL) by targeting behavioral parenting skills. It aims to develop and evaluate a new intervention called CareMeds, which will provide parents with strategies to support their children's medication routines. The study will assess the feasibility of this intervention in improving adherence rates, which are crucial for successful cancer treatment. By involving parents in the process, the research seeks to address a significant barrier to effective treatment in pediatric oncology.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 3-9 years diagnosed with Acute Lymphoblastic Leukemia.
Not a fit: Patients who are older than 11 years or those without a diagnosis of Acute Lymphoblastic Leukemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence in children with cancer, leading to better health outcomes and reduced risk of cancer relapse.
How similar studies have performed: While there have been various approaches to improve medication adherence, this specific focus on behavioral parenting skills as a novel intervention is relatively untested.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Bouchard, Elizabeth — Roswell Park Cancer Institute Corp
- Study coordinator: Bouchard, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.